Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-20

Clinical Trial Update: To Evaluate the Immunogenicity and Safety of Two Different Immunization Schedules of Rabies Vaccine (Vero Cell) [Phase 3]

View source ↗

Summary

Phase 3 trial assessing two rabies vaccine immunization schedules; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rabies Vaccine (Vero Cell) (rabies vaccine)

Snippet

Sponsor: Hualan Biological Bacterin Co. Ltd. | Conditions: Rabies Human | Phase 3 | Status: COMPLETED